XOMA Receives $750,000 Milestone Payment From AVEO Pharmaceuticals
28-Jul-2010
- USA
XOMA has signed more than 60 license and collaboration agreements with pharmaceutical and biotechnology companies related to its patented technologies and its antibody discovery, development and optimization expertise. These agreements cover a number of potential product candidates in various stages of clinical and preclinical development for which XOMA may be entitled to future milestone and royalty payments.
Most read news
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Repairing the brain
Go to page
Leibniz-Zentrum für Marine Tropenökologie (ZMT) GmbH - Bremen, Germany
Go to page
Biergans Pumpen-Vertrieb GmbH - Duisburg, Germany
Go to page
Causus_rhombeatus
Go to page
Agilent Technologies Appoints Dr. Tachi Yamada to Board of Directors
Go to page
MEDICONOMICS GmbH - Hannover, Germany
Go to page
Alan Schafer to head Population Genetics
Go to page
Scurvy
Go to page
art photonics GmbH - Berlin, Germany
Go to page
Dyax and Genzyme Initiate Pivotal Phase III Trial of Subcutaneously Administered DX-88 for Treatment of Hereditary Angioedema
Go to page
Causus_defilippii
Go to page
Biocartis named as a technology pioneer 2012 by the World Economic Forum
Go to page